Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Benjamin Dehay(Institut des Maladies Neurodégénératives), Mathieu Bourdenx(Institut des Maladies Neurodégénératives), Philippe Gorry(Université de Bordeaux), Serge Przedborski(Columbia University), Miquel Vila(Institució Catalana de Recerca i Estudis Avançats), Stéphane Hunot(Inserm), Andrew Singleton(National Institute on Aging), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Kalpana Merchant, Erwan Bézard(Université de Bordeaux), Gregory A. Petsko(MIND Research Institute), Wassilios G. Meissner(Université de Bordeaux)
Cited by 507Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis